Ken Aldape

Ken Aldape

UNVERIFIED PROFILE

Are you Ken Aldape?   Register this Author

Register author
Ken Aldape

Ken Aldape

Publications by authors named "Ken Aldape"

Are you Ken Aldape?   Register this Author

54Publications

1484Reads

32Profile Views

A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics.

Neuro Oncol 2017 05;19(5):614-624

Division of Neuro-Oncology, Department of Neurological Surgery, University of California San Francisco,San Francisco, California

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now277DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464438PMC
May 2017

Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma.

J Neurooncol 2016 08 7;129(1):147-54. Epub 2016 Jun 7.

Division of Neuro-Oncology, Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd Unit 431, Houston, TX, 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-016-2157-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021066PMC
August 2016

Glioma.

Nat Rev Dis Primers 2015 07 16;1:15017. Epub 2015 Jul 16.

Department of Neuropathology, Heinrich Heine University Düsseldorf, and German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Heidelberg, partner site Essen/Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrdp.2015.17DOI Listing
July 2015

Comparison of next-generation sequencing mutation profiling with BRAF and IDH1 mutation-specific immunohistochemistry.

Am J Surg Pathol 2015 Apr;39(4):454-61

Departments of *Hematopathology †Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000325DOI Listing
April 2015

Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.

Neuro Oncol 2013 Jul 15;15(7):829-39. Epub 2013 Mar 15.

Cancer Research Institute of Medical Science, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/not024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688008PMC
July 2013

The use of global profiling in biomarker development for gliomas.

Brain Pathol 2011 Jan;21(1):88-95

Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Tex, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1750-3639.2010.00456.xDOI Listing
January 2011

Twenty-year survival in glioblastoma: a case report and molecular profile.

Int J Radiat Oncol Biol Phys 2009 Nov 26;75(4):1162-5. Epub 2009 Mar 26.

Minneapolis Radiation Oncology, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.12.054DOI Listing
November 2009

Beyond grade: molecular pathology of malignant gliomas.

Semin Radiat Oncol 2009 Jul;19(3):142-9

Department of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S105342960900018
Publisher Site
http://dx.doi.org/10.1016/j.semradonc.2009.02.001DOI Listing
July 2009

Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402.

Brain Pathol 2008 Jul 26;18(3):360-9. Epub 2008 Mar 26.

Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1750-3639.2008.00129.xDOI Listing
July 2008

Prognostic and predictive markers in glioma and other neuroepithelial tumors.

Curr Probl Cancer 2008 May-Jun;32(3):97-123

Baylor College of Medicine/UT-MD Anderson Cancer Center program in Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.currproblcancer.2008.02.003DOI Listing
July 2008

Brain tumor stem cells.

Curr Probl Cancer 2008 May-Jun;32(3):124-42

Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.currproblcancer.2008.02.004DOI Listing
July 2008

Molecular predictors in glioblastoma: toward personalized therapy.

Arch Neurol 2008 Jul;65(7):877-83

Department of Neuro-oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 431, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archneur.65.7.877DOI Listing
July 2008

Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma.

Proc Natl Acad Sci U S A 2007 Feb 20;104(9):3466-71. Epub 2007 Feb 20.

Department of Tumor Biology and Angiogenesis, Molecular Biology, Biostatistics, and Pathology, Genentech, Inc., South San Francisco, CA 94080, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0611271104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1802005PMC
February 2007

Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms.

Clin Cancer Res 2006 Aug;12(15):4738-46

Department of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, 02114, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-06-0596DOI Listing
August 2006

Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.

BMC Cancer 2006 Apr 19;6:97. Epub 2006 Apr 19.

Department of Neurological Surgery, Brain Tumor Research Center, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-6-97DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1479358PMC
April 2006

Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells.

J Neurooncol 2005 Aug;74(1):31-40

California Pacific Medical Center Research Institute, 475 Brannan St., Suite 220, San Francisco, CA 94107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-004-5950-2DOI Listing
August 2005

Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme.

Proc Natl Acad Sci U S A 2005 Apr 12;102(16):5814-9. Epub 2005 Apr 12.

Preuss Laboratory for Molecular Neuro-oncology and Department of Neurological Surgery, University of California-San Francisco, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0402870102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC556127PMC
April 2005

Berberine sensitizes human glioma cells, but not normal glial cells, to ionizing radiation in vitro.

J Exp Ther Oncol 2004 Jul;4(2):137-43

California Pacific Medical Center Research Institute, California Pacific Medical Center Research Institute, San Francisco, CA 94115, USA.

View Article

Download full-text PDF

Source
July 2004

In vitro test of external Qigong.

BMC Complement Altern Med 2004 Mar 15;4. Epub 2004 Mar 15.

Research Institute, California Pacific Medical Center, San Francisco 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1472-6882-4-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC387832PMC
March 2004

Repeated operations for infiltrative low-grade gliomas without intervening therapy.

J Neurosurg 2003 Jun;98(6):1165-9

Department of Neurological Surgery, University of California at San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/jns.2003.98.6.1165DOI Listing
June 2003

Genetic determinants of malignancy in a mouse model for oligodendroglioma.

Cancer Res 2003 Apr;63(7):1589-95

Department of Neurology, University of California, San Francisco, California 94143-0663, USA.

View Article

Download full-text PDF

Source
April 2003

Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma.

Cancer Res 2002 Nov;62(21):6205-10

Department of Neurological Surgery, University of California, San Francisco 94143, USA.

View Article

Download full-text PDF

Source
November 2002

Hemorrhage and VEGF expression in a case of primary CNS lymphoma.

J Neurooncol 2002 May;58(1):53-6

Division of Hematology/Oncology, University of California, San Francisco 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1015887312455DOI Listing
May 2002

Localization of the neuronal class III beta-tubulin in oligodendrogliomas: comparison with Ki-67 proliferative index and 1p/19q status.

J Neuropathol Exp Neurol 2002 Apr;61(4):307-20

Department of Pediatrics, St Christopher's Hospital for Children, Philadelhpia, PA 19134, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnen/61.4.307DOI Listing
April 2002

Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.

Clin Cancer Res 2002 Jan;8(1):180-7

Department of Pathology, University of California, San Francisco, San Francisco, California 94143, USA.

View Article

Download full-text PDF

Source
January 2002